News – Page 849 – Endpoints News

Weathering the storm: Another biotech braves Covid-19 in upsized IPO

6 years ago

FDA needs three more months to review Roche's SMA drug — giving Biogen, Novartis some relief

6 years ago

Zai Lab finds latest target in Regeneron’s bispecific, paying up to $190M for Chinese rights

6 years ago

Covid-19 roundup: EU‘s top scientist resigns in rebuke to agency’s Covid response; J&J posts negative data for ...

6 years ago

Acceleron's PAH drug gets the FDA's red carpet treatment with breakthrough status

6 years ago

Roche makes a platform play, betting $190M in cash on Arrakis’ long-haul plans to drug RNA

6 years ago

‘If grippe condemns, the secondary infections execute’: What the coronavirus pandemic means for the field of ...

6 years ago

Blasted by PhIII failure, a struggling Sage axes 340 staffers and bunkers down to survive the storm

6 years ago

Wellcome looks for backers of an $8B-plus Covid-19 fund; ReNeuron signs on another pharma partner

6 years ago

Merck-partnered antibody maker readies $300M IPO as HKEX picks up pace

6 years ago

Pivotal failure crumbles stock for Michigan’s once-promising Millendo

6 years ago

Biopharma billionaires dominate Forbes' list of the world's top 10 wealthiest healthcare execs — and the pandemic ...

6 years ago

Hospitals report ‘severe shortages’ of Covid-19 tests, HHS survey finds

6 years ago

Covid-19 roundup: Ex-FDA commish Gottlieb joins Republican governor's coronavirus team; Pharma approval ratings ...

6 years ago

Gilead gets in on the microbiome game with a $38M pact, up to $1.5B in milestones

6 years ago

Another protein degradation biotech emerges, with the promise of a new approach from an old hand

6 years ago

Who's doing deals in the midst of a crippling pandemic? Here are the top 10 players for March

6 years ago

Ready to declare a definitive comeback in two months, Immunomedics stops PhIII early, recruits new CEO

6 years ago

Another day, another boatload for biotech. Deerfield adds $840M to rush of venture dollars

6 years ago

Small molecules, biologics and now gene therapies: Germany's Evotec adds another feather to its R&D cap

6 years ago

A pair of PhIII failures spells last rites for Menlo’s once-promising Merck drug

6 years ago

After putting aside a bitter legal feud, Alnylam and Dicerna chiefs make nice with an RNAi collaboration

6 years ago

GSK's Hal Barron buys a $250M stake in George Scangos' Vir and makes a beeline to the clinic with Covid-19 antibodies

6 years ago

Covid-19 roundup: Inovio gets FDA greenlight to enter human trials; Trump pushes untested malaria drugs again

6 years ago

First page Previous page 846 847 848849850 851 852 Next page Last page